Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00UDP
|
||||
Former ID |
DCL001082
|
||||
Drug Name |
Terameprocol
|
||||
Synonyms |
EM-1421; Terameprocol (INN/USAN); Meso-Tetra-O-methylnordihydroguaiaretic acid; Meso-Tetramethoxy-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol; Meso-1,4-Bis-(3,4-dimethoxyphenyl)-2,3-dimethylbutane; 4-[(2S,3R)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Phase 2 | [529346] | ||
Company |
Erimos
|
||||
Structure |
Download2D MOL |
||||
Formula |
C22H30O4
|
||||
Canonical SMILES |
CC(CC1=CC(=C(C=C1)OC)OC)C(C)CC2=CC(=C(C=C2)OC)OC
|
||||
InChI |
1S/C22H30O4/c1-15(11-17-7-9-19(23-3)21(13-17)25-5)16(2)12-18-8-10-20(24-4)22(14-18)26-6/h7-10,13-16H,11-12H2,1-6H3/t15-,16+
|
||||
InChIKey |
ORQFDHFZSMXRLM-IYBDPMFKSA-N
|
||||
CAS Number |
CAS 5701-82-6
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Transcription factor Sp1 | Target Info | Modulator | [529346] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.